Searched for
CELSUS
Quote of the day by Stoic philosopher Epictetus: 'Do not seek for things to happen as you wish, but wish for things to happen as they do happen.' ; lessons on how to embrace reality and stop stressing from Ancient Greek scholarAncient Greek philosopher Epictetus advised embracing reality rather than demanding life conform to our wishes. Much suffering stems from u...- Family office of Gland Pharma's former promoter acquires GBJ HotelsKP Advisory Services, the family office of the promoter Ravi Penmetsa, acquired the five-star property last week in Coimbatore under the co...
- Aurobindo, Cadila, UPL in fray to acquire bankrupt Sterling BiotechThe liquidator had invited bids on July 21 for the world’s sixth-largest manufacturer of pharmaceutical gelatin to sell the company as a go...
- Gland Pharma IPO allotment status: Here's how to check itAs per the IPO prospectus, the basis of allotment for the Gland Pharma IPO is likely on Tuesday while the refund process would be initiated...
- Gland Pharma issue subscribed 2.06 timesGland Pharma’s initial public offer (IPO), the biggest ever offering in the Indian pharmaceutical sector — was subscribed 2.06 times on the...
- Gland Pharma IPO off to lacklustre start, subscribed 4% on Day 1The IPO is a mix of a fresh issue of shares worth Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuationsGland Pharma’s IPO is India’s largest pharmaceutical IPO ever.
- Gland Pharma raises Rs 1944 crore before IPOThe IPO will open from 9 November for subscription and will close on 11 November.
- Grey market premium fizzles out for Gland Pharma after fixing price bandThe Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer...
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per shareThe Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...
- India's largest pharma IPO set to hit marketThis will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, whic...
- Gland Pharma gets Sebi's go-ahead to float IPOThe company filed draft papers in July and obtained Sebi's observation on October 19 to float an IPO, an update with the capital markets sh...
- China’s Fosun plans D-Street debut for Gland PharmaThe Hyderabad-based Gland Pharma has filed a draft red herring prospectus with capital market regulator Securities and Exchange Board of In...
- 74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
- Divi’s, Gland, Fidelity enter race to buy Orchid PharmaThe move comes even as Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over ...
- Blackstone, Strides, Nectar lead race for Orchid PharmaShares of Orchid closed at Rs 17 on Friday, down 5 per cent.
- Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio ChemicalsGland Pharma makes and markets specialised injectable formulations for generic versions of drugs, it also manufactures a limited quantity o...
- Government approves eight FDI proposals worth Rs 1,024 croreThe government has approved eight foreign investment proposals, including plans by L&T Infrastructure Development Projects and Welspun Rene...
- KKR-Gland Pharma deal gets Competition Commission nodCompetition Commission of India (CCI) has given nod for the proposal, which involves multiple transactions, saying the deal does not raise ...
- Down history's pathThere’s little left of the fabled Temple of Artemis, but Ephesus has other wonders. One has to see it to appreciate it.
Load More
